Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.
Understanding antibody responses will be key to offset coronavirus variants' evasion of earlier immunity.
While Omicron variants ratchet up immune evasion, study suggests current boosters intensify protections against serious infection
Across 16 countries studied, spikes in influenza-like illnesses emerged 3 months before the first COVID-19 cases were reported.
